1
0
0
News
Neueingänge
www.aerzteblatt.de
Medizin/Naturwissenschaft Robert J. Damstra: Diagnostic and the…utical aspects of lymphedema. Rabe Medical Publishing, Bonn 2010, 232 Seiten, kartoniert,...
Dokumente zum Namen
Challenging gold standard hematology diagnostics through ...Wiley
onlinelibrary.wiley.com
von T Haferlach — 8Matek C, Krappe S, Münzenmayer C, Haferlach T, Marr C. Highly accurate differentiation of bone marrow cell morphologies using deep neural ... › i...
[PDF] 11 th Annual Symposium of the European LeukemiaNet. 15 th...
silo.tips
Download 11 th Annual Symposium of the European LeukemiaNet. 15 th Annual Symposium of the German Competence Network Acu...
novel molecular markers in myeloid malignancies - HALhal.science
hal.science
von U Bacher · · Zitiert von: 80 — C. Haferlach .S. Schnittger .A. Kohlmann .W. Kern . T. Haferlach (*). MLL Munich Leukemia Laboratory,. , Munich, Germany. Kern, C. Haferlach, and S. Schnittger, A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in patients with acute ... › hal › document › html_references
Wissenschaftliche Veröffentlichungen
Annals of Oncology | Tumor mutation burden as an immunotherapy...
www.sciencedirect.com
C. Haferlach, T. Haferlach. Pages : Download PDF. select article Passion for immune checkpoint blockade in triple negative breast cancer: Comment on ... › issue
Veröffentlichungen allgemein
Gene expression analyses in acute myeloid leukaemia (AML): current...
link.springer.com
Gene expression analyses based on the microarray technique allow the simultaneous investigation of the expression patterns of tens of thousands of genes. G
European Research Initiative on CLL (ERIC)European Research Initiative on CLL
www.ericll.org
— Speakers: B. Espinet and C. Haferlach – Tailoring treatment: clinical considerations Auditorium. AUDITORIUM. › uploads › › ER...
Abstract: A Database and Neural Network for Highly Accurate ...springer.com
link.springer.com
von C Matek · — Matek C, Krappe S, Münzenmayer C, Haferlach T, Marr C. An expert-annotated reference dataset for bone marrow cytomorphology. The Cancer Imaging ... › chapter
Sonstiges
Das MLL bei der ASH-Conference | MLL
www.mll.com
Autoren: J. Müller, C. Haferlach, H. Ruge, H. Müller, I. Fuhrmann, M. Meggendorfer, M.-L. Müller, W. Kern, T. Haferlach, A. Stengel. Die akute lymphoblastische T-Zell-Leukämie (T-ALL) ist eine seltene aggressive Neoplasie, die ca. 20 % aller ALL-Fälle ausmacht. Sie tritt häufiger bei Erwachsenen auf als bei Kindern, obwohl die Inzidenz ...
62. ASH Annual Meeting & Exposition - a follow-up report - MLLMLL Münchner Leukämielabor
www.mll.com
C. Haferlach then presented the current state of affairs for classic chromosomal analysis: The MLL has now succeeded in developing algorithms together with ... › 62-ash-an...
Diagnostic Tools in the Indications for Allogeneic Stem Cell ...Transplantation and Cellular Therapy
www.astctjournal.org
von U Bacher · · Zitiert von: 15 — Financial disclosure: C. Haferlach, S. Schnittger, W. Kern, and T. Haferlach declare ownership of the MLL Munich Leukemia Laboratory. › article › fulltext
6.7 Microarray-Analysen - ONKODIN
www.onkodin.de
von T Haferlach · — Autor/en: T. Haferlach, U. Bacher, A. Kohlmann, C. Haferlach Letzte Änderung: Inhaltsübersicht: Entwicklung und Bedeutung ... › ...
MHP Münchner Hämatologie Praxis, Prof. Dr. Dr. Torsten Haferlach ...North Data
www.northdata.de
biologischen medizinischen Kooperationsgemeinschaft der vorgenannten Partner mit den weiteren Partnern C. Haferlach und S. Schnittger. Jeder Partner vertritt ... › ... › Neueintragungen
AML with mutated NPM1 carrying a normal or aberrant karyotype show...
cyberleninka.org
Similar topics of scientific paper in Clinical medicine , author of scholarly article — C. Haferlach, C. Mecucci, S. Schnittger, A. Kohlmann, M. Mancini, et al.
Ohne TitelCNRS
dumas.ccsd.cnrs.fr
Grossmann, C. Haferlach, T. Haferlach et al., STAT3 mutations are highly specific for large granular lymphocytic leukemia, Leukemia, ... › html_...
C. M. Annunziata, R. E. Davis, Y. Demchenko, W. Bellamy, A ...
hal.archives-ouvertes.fr
C. Haferlach, F. Dicker, S. Schnittger, W. Kern, and T. Haferlach, Comprehensive genetic characterization of CLL: a study on 506 cases analysed with ... › ht...
SOX11 overexpression is a specific marker for mantle cell ...Gale
go.gale.com
von M Meggendorfer · · Zitiert von: 56 — Gale Academic OneFile includes SOX11 overexpression is a specific marker for mantle ce by M. Meggendorfer, W. Kern, C. Haferlach,. Click to explore. › i.do
B. Falini, C. Mecucci, E. Tiacci, M. Alcalay, R. Rosati et al ...hal.archives-ouvertes.fr › html_ref...
hal.archives-ouvertes.fr
U. Bacher, T. Haferlach, W. Kern, C. Haferlach, and S. Schnittger, A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome ...
European recommendations and quality assurance for cytogenomic...
research.rug.nl
von KA Rack · · Zitiert von: 72 — K. A. Rack, E. van den Berg, C. Haferlach, H. B. Beverloo, D. Costa, B. Espinet, N. Foot, S. Jeffries, K. Martin, S. O'Connor, J. Schoumans, P. Talley, ... › publications
Safety and efficacy of imatinib in chronic eosinophilic ...University of Southampton
eprints.soton.ac.uk
von G Metzgeroth · · Zitiert von: 150 — Author: C. Haferlach. Author: A. Fabarius. Author: S. Schmittger. Author: D. Grimwade. Author: N.C. Cross · ORCID iD. Author: R. Hehlmann. › ...
Marr Lab | Helmholtz MunichHelmholtz Zentrum München
www.helmholtz-munich.de
Matek, C. ; Krappe, S. ; Münzenmayer, C. ; Haferlach, T. ; Marr, C. Abstract: A database and neural network for highly accurate classification of single bone ... › aih › marr-group
Unrelated clones in AML/MDS - characterisation and prognostic...
portal.research.lu.se
von S Fischer · — S. Fischer, D. Haase, C. Haferlach, G. Bardi, M. Slovak, Bertil Johansson, K. Ohyashiki, F. Sole, V Ecclache, P. Greenberg, M. M. LeBeau, J. Bennett, ... › unrela...
Minimal Residual Disease Detection in Acute Leukemia ...KoreaMed
synapse.koreamed.org
von YU Cho · Zitiert von: 1 — Kern W., Haferlach C., Haferlach T., Schnittger S. Monitoring of minimal residual disease in acute myeloid leukemia. Cancer :4–16. › ar...
Referenzlabore für Zyto- und Molekulargenetik | Kinderkrebsinfo
www.gpoh.de
— C. Haferlach MHP Münchner Hämatologiepraxis München Tel.: + Fax.: + › content › leukaemien › index_ger
2019 | National Cancer Center Reseach Institute国立がん研究センター
www.ncc.go.jp
... Stevenson, K. E., Neuberg, D., Maciejewski, J. P., Nazha, A., Sekeres, M. A., Ebert, B. L., Garcia-Manero, G., Haferlach, C., Haferlach, T., Kern, W., ... › paper
TP53 mutation status divides myelodysplastic syndromes with ...www.rdm.ox.ac.uk › publications
www.rdm.ox.ac.uk
... Ebert BL., Garcia-Manero G., Haferlach C., Haferlach T., Kern W., Ogawa S., Nagata Y., Yoshida K., Graubert TA., Walter MJ., List AF., Komrokji RS., Padron E., ...
STAT3 Signaling in Cancer - Scientific Research PublishingScientific Research Publishing
www.scirp.org
Fasan, A., Kern, W., Grossmann, V., Haferlach, C., Haferlach, T. and Schnittger, S. (2013) STAT3 Mutations Are Highly Specific for Large Granular ... › reference
Molecular profiling of chronic myelomonocytic leukemia reveals...
eprints.soton.ac.uk
von V Grossmann · · Zitiert von: 145 — Grossmann, V., Kohlmann, A., Eder, C., Haferlach, C., Kern, W., Cross, N.C.P., Haferlach, T. and Schnittger, S. (2011) Molecular profiling of chronic ... › ...
Verwandte Suchanfragen zu C. Haferlach
|
Personen Vorname Name "Haferlach" (19) |
sortiert nach Relevanz / Datum